Digital platforms may play an important role in transforming respiratory care management by empowering patients to make sustainable behavior changes and enabling clinicians to deliver the right care to the right patient at the right time with medically actionable insights.
Propeller Health and ResMed presented several abstracts at the 2023 European Respiratory Society (ERS) International Congress, many of which examined how digital health platforms can be leveraged — and scaled — to drive clinical outcomes in respiratory care. Read brief summaries of the abstracts below.
Digital platforms may enhance asthma outcomes when integrated with virtual care
Summary: A wide range of studies have shown that digital self-management platforms improve clinical outcomes in asthma, but few have explored the added benefit of a virtual clinical care team in combination with a digital self-management platform. As such, this study examined the added value of a virtual care team (Evernorth) in combination with Propeller’s digital self-management platform. While the digital-self-management platform was associated with improved asthma outcomes, we observed further enhanced clinical outcomes and program retention when the digital platform was also paired with virtual care. These findings not only highlight the value of digital health platforms, but also demonstrate the enhanced value of a hybrid digital and clinical approach to patient care in asthma.
A real-world evaluation of a digital self-management and adherence support system in patients with severe asthma
Summary: Suboptimal medication adherence can lead to poor symptom control and inappropriate treatment escalation in asthma. As such, assessing and optimizing medication adherence is a critical part of asthma management. Using Propeller’s digital health platform, researchers at Portsmouth and Manchester Severe Asthma Services in the UK assessed the platform’s feasibility and effectiveness in promoting adherence among real world patients with severe asthma. At six months, the majority (72%) of patients continued using the platform, and most patients (68%) achieved at least 80% controller adherence. Furthermore, patients who continued to utilize Propeller showed significant improvements in asthma control, quality of life, airway inflammation, and healthcare utilization. These results highlight the value of digital platforms in the management of severe asthma.
For any questions about Propeller’s peer-reviewed clinical research, please reach out to email@example.com.